According to the World Health Organisation (WHO), 1 out of 4 people suffers from a mental disorder, and in the United States alone 250 million people are estimated to suffer from depression. The pandemic has worsened this trend, significantly multiplying depression, anxiety and post-traumatic stress rates in populations affected by Covid. Meanwhile, the WHO estimates that, at a global scale, only 15-25% of the people suffering from a mental illness are receiving some kind of support.
To provide an integrated technical solution for a cognitive-behavioural therapy that helps prevent mental health issues and supports medical therapies in disorders such as OCD, anxiety, depression and body dysmorphia, and is evidence-based, ethical, personalised and accessible to “normal” population.
Koa measures the efficiency of its treatments in patients and inequalities in impacts according to types of population to avoid biases. In addition, Koa measures the reduction in the cost of its treatments and the number of people receiving them.